(Total Views: 600)
Posted On: 01/06/2021 5:38:28 PM
Post# of 145873
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: invisioner #71562
If the mortality rate wasn't significantly better than for patients who enter the hospital and receive a variety of treatments, why would the FDA allow wider EIND and Open Label use.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)